学术探索
学术期刊
学术作者
新闻热点
数据分析
智能评审
水飞蓟宾纳米混悬剂的制备及大鼠体内药动学研究
被引:9
作者
:
论文数:
引用数:
h-index:
机构:
汪巍
论文数:
引用数:
h-index:
机构:
赵暖
论文数:
引用数:
h-index:
机构:
栾立标
论文数:
引用数:
h-index:
机构:
韦琼华
机构
:
[1]
中国药科大学药学院,药剂教研室
来源
:
抗感染药学
|
2009年
/ 6卷
/ 03期
关键词
:
水飞蓟宾;
纳米混悬剂;
自微乳化;
高速分散;
药动学;
D O I
:
暂无
中图分类号
:
TQ461 [中草药制剂的生产];
R285 [中药药理学];
学科分类号
:
091003
[林草生态工程学]
;
100806
[中药药理学]
;
摘要
:
目的:探讨静脉注射用水飞蓟宾纳米混悬剂的制备,并评价其大鼠静注给药后的药动学。方法:通过对水飞蓟宾纳米混悬剂理化性质及稳定性的评价,考察水飞蓟宾纳米混悬剂的制备方法、处方工艺,并以溶液剂为参照考察其在大鼠体内的药动学行为。结果:水飞蓟宾纳米混悬剂的平均粒径是(268.90±9.20)nm,多分散性为0.22±0.12。水飞蓟宾溶液剂及纳米混悬剂的药时曲线下面积分别为(34.92±0.98)μg·h·mL-1和(57.12±3.20)μg·h·mL-1,消除半衰期(t1/2)分别为(3.05±0.06)h和(6.14±0.42)h。结论:制备的水飞蓟宾纳米混悬剂理化性质比较稳定,与溶?液剂相比,延长了药物在体内的驻留时间,具有一定的缓释效果。
引用
收藏
页码:153 / 157
页数:5
相关论文
共 3 条
[1]
Silymarin: A review of its clinical properties in the management of hepatic disorders
[J].
Wellington, K
论文数:
0
引用数:
0
h-index:
0
机构:
Adis Int Ltd, Auckland 10, New Zealand
Adis Int Ltd, Auckland 10, New Zealand
Wellington, K
;
Jarvis, B
论文数:
0
引用数:
0
h-index:
0
机构:
Adis Int Ltd, Auckland 10, New Zealand
Adis Int Ltd, Auckland 10, New Zealand
Jarvis, B
.
BIODRUGS,
2001,
15
(07)
:465
-489
[2]
Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide
[J].
Jacobs, C
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Berlin, Dept Pharmceut Biopharmaceut & Biotechnol, D-12196 Berlin, Germany
Free Univ Berlin, Dept Pharmceut Biopharmaceut & Biotechnol, D-12196 Berlin, Germany
Jacobs, C
;
Kayser, O
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Berlin, Dept Pharmceut Biopharmaceut & Biotechnol, D-12196 Berlin, Germany
Free Univ Berlin, Dept Pharmceut Biopharmaceut & Biotechnol, D-12196 Berlin, Germany
Kayser, O
;
Müller, RH
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Berlin, Dept Pharmceut Biopharmaceut & Biotechnol, D-12196 Berlin, Germany
Free Univ Berlin, Dept Pharmceut Biopharmaceut & Biotechnol, D-12196 Berlin, Germany
Müller, RH
.
INTERNATIONAL JOURNAL OF PHARMACEUTICS,
2000,
196
(02)
:161
-164
[3]
Nanosuspensions for the formulation of poorly soluble drugs.[J].Rainer H Müller;Katrin Peters.International Journal of Pharmaceutics.1998, 2
←
1
→
共 3 条
[1]
Silymarin: A review of its clinical properties in the management of hepatic disorders
[J].
Wellington, K
论文数:
0
引用数:
0
h-index:
0
机构:
Adis Int Ltd, Auckland 10, New Zealand
Adis Int Ltd, Auckland 10, New Zealand
Wellington, K
;
Jarvis, B
论文数:
0
引用数:
0
h-index:
0
机构:
Adis Int Ltd, Auckland 10, New Zealand
Adis Int Ltd, Auckland 10, New Zealand
Jarvis, B
.
BIODRUGS,
2001,
15
(07)
:465
-489
[2]
Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide
[J].
Jacobs, C
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Berlin, Dept Pharmceut Biopharmaceut & Biotechnol, D-12196 Berlin, Germany
Free Univ Berlin, Dept Pharmceut Biopharmaceut & Biotechnol, D-12196 Berlin, Germany
Jacobs, C
;
Kayser, O
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Berlin, Dept Pharmceut Biopharmaceut & Biotechnol, D-12196 Berlin, Germany
Free Univ Berlin, Dept Pharmceut Biopharmaceut & Biotechnol, D-12196 Berlin, Germany
Kayser, O
;
Müller, RH
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ Berlin, Dept Pharmceut Biopharmaceut & Biotechnol, D-12196 Berlin, Germany
Free Univ Berlin, Dept Pharmceut Biopharmaceut & Biotechnol, D-12196 Berlin, Germany
Müller, RH
.
INTERNATIONAL JOURNAL OF PHARMACEUTICS,
2000,
196
(02)
:161
-164
[3]
Nanosuspensions for the formulation of poorly soluble drugs.[J].Rainer H Müller;Katrin Peters.International Journal of Pharmaceutics.1998, 2
←
1
→